Compile Data Set for Download or QSAR
Report error Found 38 Enz. Inhib. hit(s) with all data for entry = 2766
TargetGlycogen phosphorylase, liver form(Human)
Astrazeneca

LigandPNGBDBM24393(2,3-dichloro-N-{1-[(2R)-2,3-dihydroxypropyl]-2-oxo...)
Affinity DataIC50: 2nMAssay Description:The inhibitory activity of the test compounds against human recombinant glycogen phosphorylase a (GPa) was monitored using 96-well microplate format....More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/15/2008
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Astrazeneca

LigandPNGBDBM24385(2,3-dichloro-N-[1-(2-hydroxyethyl)-2-oxo-1,2,3,4-t...)
Affinity DataIC50: 7nMpH: 7.2 T: 2°CAssay Description:The inhibitory activity of the test compounds against human recombinant glycogen phosphorylase a (GPa) was monitored using 96-well microplate format....More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/15/2008
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Astrazeneca

LigandPNGBDBM24399(2-chloro-N-[(3S)-1-[(2S)-2,3-dihydroxypropyl]-2-ox...)
Affinity DataIC50: 12nMAssay Description:The inhibitory activity of the test compounds against human recombinant glycogen phosphorylase a (GPa) was monitored using 96-well microplate format....More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/15/2008
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Astrazeneca

LigandPNGBDBM24387(5-chloro-N-[1-(2-hydroxyethyl)-2-oxo-1,2,3,4-tetra...)
Affinity DataIC50: 17nMpH: 7.2 T: 2°CAssay Description:The inhibitory activity of the test compounds against human recombinant glycogen phosphorylase a (GPa) was monitored using 96-well microplate format....More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/15/2008
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Astrazeneca

LigandPNGBDBM24398(2-chloro-N-[(3R)-1-[(2S)-2,3-dihydroxypropyl]-2-ox...)
Affinity DataIC50: 21nMAssay Description:The inhibitory activity of the test compounds against human recombinant glycogen phosphorylase a (GPa) was monitored using 96-well microplate format....More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/15/2008
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Astrazeneca

LigandPNGBDBM24391(2-chloro-N-[1-(3-hydroxypropyl)-2-oxo-1,2,3,4-tetr...)
Affinity DataIC50: 21nMpH: 7.2 T: 2°CAssay Description:The inhibitory activity of the test compounds against human recombinant glycogen phosphorylase a (GPa) was monitored using 96-well microplate format....More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/15/2008
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Astrazeneca

LigandPNGBDBM24386(2-chloro-N-[1-(2-hydroxyethyl)-2-oxo-1,2,3,4-tetra...)
Affinity DataIC50: 26nMpH: 7.2 T: 2°CAssay Description:The inhibitory activity of the test compounds against human recombinant glycogen phosphorylase a (GPa) was monitored using 96-well microplate format....More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/15/2008
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Astrazeneca

LigandPNGBDBM24397(2-chloro-N-[(3S)-1-[(2R)-2,3-dihydroxypropyl]-2-ox...)
Affinity DataIC50: 27nMAssay Description:The inhibitory activity of the test compounds against human recombinant glycogen phosphorylase a (GPa) was monitored using 96-well microplate format....More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/15/2008
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Astrazeneca

LigandPNGBDBM24384(2-chloro-N-[1-(cyanomethyl)-2-oxo-1,2,3,4-tetrahyd...)
Affinity DataIC50: 28nMpH: 7.2 T: 2°CAssay Description:The inhibitory activity of the test compounds against human recombinant glycogen phosphorylase a (GPa) was monitored using 96-well microplate format....More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/15/2008
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Astrazeneca

LigandPNGBDBM24394(2-chloro-N-{1-[(2R)-2,3-dihydroxypropyl]-2-oxo-1,2...)
Affinity DataIC50: 29nMAssay Description:The inhibitory activity of the test compounds against human recombinant glycogen phosphorylase a (GPa) was monitored using 96-well microplate format....More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/15/2008
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Astrazeneca

LigandPNGBDBM24388(2,3-dichloro-N-{1-[3-hydroxy-2-(hydroxymethyl)prop...)
Affinity DataIC50: 38nMpH: 7.2 T: 2°CAssay Description:The inhibitory activity of the test compounds against human recombinant glycogen phosphorylase a (GPa) was monitored using 96-well microplate format....More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/15/2008
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Astrazeneca

LigandPNGBDBM24396(2-chloro-N-[(3R)-1-[(2R)-2,3-dihydroxypropyl]-2-ox...)
Affinity DataIC50: 40nMAssay Description:The inhibitory activity of the test compounds against human recombinant glycogen phosphorylase a (GPa) was monitored using 96-well microplate format....More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/15/2008
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Astrazeneca

LigandPNGBDBM24363(2-chloro-N-(2-oxo-1,2,3,4-tetrahydroquinolin-3-yl)...)
Affinity DataIC50: 41nMpH: 7.2 T: 2°CAssay Description:The inhibitory activity of the test compounds against human recombinant glycogen phosphorylase a (GPa) was monitored using 96-well microplate format....More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/15/2008
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Astrazeneca

LigandPNGBDBM24395(5-chloro-N-{1-[(2R)-2,3-dihydroxypropyl]-2-oxo-1,2...)
Affinity DataIC50: 44nMAssay Description:The inhibitory activity of the test compounds against human recombinant glycogen phosphorylase a (GPa) was monitored using 96-well microplate format....More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/15/2008
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Astrazeneca

LigandPNGBDBM24392(2-chloro-N-[1-(2-hydroxybutyl)-2-oxo-1,2,3,4-tetra...)
Affinity DataIC50: 44nMAssay Description:The inhibitory activity of the test compounds against human recombinant glycogen phosphorylase a (GPa) was monitored using 96-well microplate format....More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/15/2008
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Astrazeneca

LigandPNGBDBM24367(2-chloro-N-[1-(2-methanesulfinylethyl)-2-oxo-1,2,3...)
Affinity DataIC50: 48nMpH: 7.2 T: 2°CAssay Description:The inhibitory activity of the test compounds against human recombinant glycogen phosphorylase a (GPa) was monitored using 96-well microplate format....More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/15/2008
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Astrazeneca

LigandPNGBDBM24365(2-chloro-N-[1-(2-methoxyethyl)-2-oxo-1,2,3,4-tetra...)
Affinity DataIC50: 50nMpH: 7.2 T: 2°CAssay Description:The inhibitory activity of the test compounds against human recombinant glycogen phosphorylase a (GPa) was monitored using 96-well microplate format....More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/15/2008
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Astrazeneca

LigandPNGBDBM24389(2-chloro-N-{1-[3-hydroxy-2-(hydroxymethyl)propyl]-...)
Affinity DataIC50: 60nMpH: 7.2 T: 2°CAssay Description:The inhibitory activity of the test compounds against human recombinant glycogen phosphorylase a (GPa) was monitored using 96-well microplate format....More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/15/2008
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Astrazeneca

LigandPNGBDBM24368(2-chloro-N-[1-(2-methanesulfonylethyl)-2-oxo-1,2,3...)
Affinity DataIC50: 63nMpH: 7.2 T: 2°CAssay Description:The inhibitory activity of the test compounds against human recombinant glycogen phosphorylase a (GPa) was monitored using 96-well microplate format....More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/15/2008
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Astrazeneca

LigandPNGBDBM24370(2-[3-({2,3-dichloro-4H-thieno[3,2-b]pyrrole-5-}ami...)
Affinity DataIC50: 63nMpH: 7.2 T: 2°CAssay Description:The inhibitory activity of the test compounds against human recombinant glycogen phosphorylase a (GPa) was monitored using 96-well microplate format....More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/15/2008
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Astrazeneca

LigandPNGBDBM24390(5-chloro-N-{1-[3-hydroxy-2-(hydroxymethyl)propyl]-...)
Affinity DataIC50: 66nMpH: 7.2 T: 2°CAssay Description:The inhibitory activity of the test compounds against human recombinant glycogen phosphorylase a (GPa) was monitored using 96-well microplate format....More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/15/2008
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Astrazeneca

LigandPNGBDBM24382(2-chloro-N-{1-[(N'-hydroxycarbamimidoyl)methyl]-2-...)
Affinity DataIC50: 75nMpH: 7.2 T: 2°CAssay Description:The inhibitory activity of the test compounds against human recombinant glycogen phosphorylase a (GPa) was monitored using 96-well microplate format....More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/15/2008
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Astrazeneca

LigandPNGBDBM24373(2-chloro-N-{1-[(methylcarbamoyl)methyl]-2-oxo-1,2,...)
Affinity DataIC50: 79nMpH: 7.2 T: 2°CAssay Description:The inhibitory activity of the test compounds against human recombinant glycogen phosphorylase a (GPa) was monitored using 96-well microplate format....More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/15/2008
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Astrazeneca

LigandPNGBDBM24383(methyl 2-[3-({2-chloro-6H-thieno[2,3-b]pyrrole-5-}...)
Affinity DataIC50: 84nMpH: 7.2 T: 2°CAssay Description:The inhibitory activity of the test compounds against human recombinant glycogen phosphorylase a (GPa) was monitored using 96-well microplate format....More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/15/2008
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Astrazeneca

LigandPNGBDBM24369(2-chloro-N-[2-oxo-1-(2-oxobutyl)-1,2,3,4-tetrahydr...)
Affinity DataIC50: 84nMpH: 7.2 T: 2°CAssay Description:The inhibitory activity of the test compounds against human recombinant glycogen phosphorylase a (GPa) was monitored using 96-well microplate format....More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/15/2008
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Astrazeneca

LigandPNGBDBM24376(2-chloro-N-{1-[(hydroxycarbamoyl)methyl]-2-oxo-1,2...)
Affinity DataIC50: 103nMpH: 7.2 T: 2°CAssay Description:The inhibitory activity of the test compounds against human recombinant glycogen phosphorylase a (GPa) was monitored using 96-well microplate format....More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/15/2008
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Astrazeneca

LigandPNGBDBM24379(2-chloro-N-(1-{[(1,3-dihydroxypropan-2-yl)carbamoy...)
Affinity DataIC50: 104nMpH: 7.2 T: 2°CAssay Description:The inhibitory activity of the test compounds against human recombinant glycogen phosphorylase a (GPa) was monitored using 96-well microplate format....More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/15/2008
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Astrazeneca

LigandPNGBDBM24377(2-chloro-N-(1-{[(2-hydroxyethyl)carbamoyl]methyl}-...)
Affinity DataIC50: 121nMpH: 7.2 T: 2°CAssay Description:The inhibitory activity of the test compounds against human recombinant glycogen phosphorylase a (GPa) was monitored using 96-well microplate format....More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/15/2008
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Astrazeneca

LigandPNGBDBM24361(CHEMBL373749 | 2,3-dichloro-N-(2-oxo-1,2,3,4-tetra...)
Affinity DataIC50: 132nMpH: 7.2 T: 2°CAssay Description:The inhibitory activity of the test compounds against human recombinant glycogen phosphorylase a (GPa) was monitored using 96-well microplate format....More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/15/2008
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Astrazeneca

LigandPNGBDBM24372(N-[1-(carbamoylmethyl)-2-oxo-1,2,3,4-tetrahydroqui...)
Affinity DataIC50: 135nMpH: 7.2 T: 2°CAssay Description:The inhibitory activity of the test compounds against human recombinant glycogen phosphorylase a (GPa) was monitored using 96-well microplate format....More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/15/2008
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Astrazeneca

LigandPNGBDBM24380(2-chloro-N-(1-{2-[(3R,4S)-3,4-dihydroxypyrrolidin-...)
Affinity DataIC50: 140nMpH: 7.2 T: 2°CAssay Description:The inhibitory activity of the test compounds against human recombinant glycogen phosphorylase a (GPa) was monitored using 96-well microplate format....More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/15/2008
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Astrazeneca

LigandPNGBDBM24375(2-chloro-N-{1-[2-(methylcarbamoyl)ethyl]-2-oxo-1,2...)
Affinity DataIC50: 150nMpH: 7.2 T: 2°CAssay Description:The inhibitory activity of the test compounds against human recombinant glycogen phosphorylase a (GPa) was monitored using 96-well microplate format....More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/15/2008
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Astrazeneca

LigandPNGBDBM24374(2-chloro-N-{1-[(dimethylcarbamoyl)methyl]-2-oxo-1,...)
Affinity DataIC50: 161nMpH: 7.2 T: 2°CAssay Description:The inhibitory activity of the test compounds against human recombinant glycogen phosphorylase a (GPa) was monitored using 96-well microplate format....More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/15/2008
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Astrazeneca

LigandPNGBDBM24366(2-chloro-N-{1-[2-(methylsulfanyl)ethyl]-2-oxo-1,2,...)
Affinity DataIC50: 163nMpH: 7.2 T: 2°CAssay Description:The inhibitory activity of the test compounds against human recombinant glycogen phosphorylase a (GPa) was monitored using 96-well microplate format....More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/15/2008
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Astrazeneca

LigandPNGBDBM24364(2-chloro-N-(1-methyl-2-oxo-1,2,3,4-tetrahydroquino...)
Affinity DataIC50: 223nMpH: 7.2 T: 2°CAssay Description:The inhibitory activity of the test compounds against human recombinant glycogen phosphorylase a (GPa) was monitored using 96-well microplate format....More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/15/2008
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Astrazeneca

LigandPNGBDBM24371(2-{3-[(5-chloro-1H-indole-2-)amido]-2-oxo-1,2,3,4-...)
Affinity DataIC50: 237nMpH: 7.2 T: 2°CAssay Description:The inhibitory activity of the test compounds against human recombinant glycogen phosphorylase a (GPa) was monitored using 96-well microplate format....More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/15/2008
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Astrazeneca

LigandPNGBDBM24381(2-chloro-N-{1-[(methanesulfonylcarbamoyl)methyl]-2...)
Affinity DataIC50: 399nMpH: 7.2 T: 2°CAssay Description:The inhibitory activity of the test compounds against human recombinant glycogen phosphorylase a (GPa) was monitored using 96-well microplate format....More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/15/2008
Entry Details Article
PubMed
TargetGlycogen phosphorylase, liver form(Human)
Astrazeneca

LigandPNGBDBM24378(2-chloro-N-{1-[2-(4-hydroxypiperidin-1-yl)-2-oxoet...)
Affinity DataIC50: 709nMpH: 7.2 T: 2°CAssay Description:The inhibitory activity of the test compounds against human recombinant glycogen phosphorylase a (GPa) was monitored using 96-well microplate format....More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/15/2008
Entry Details Article
PubMed